Skip to main content
. 2017 May 19;18(5):1094. doi: 10.3390/ijms18051094
CI Confidence interval
DPC4 Deleted in pancreatic cancer 4
FFPE Formalin fixed paraffin embedded
FOLFIRINOX 5-FU, folinic acid, irinotecan, oxaliplatin
HR Hazard ratio
IHC Immunohistochemistry
KPS Karnofsky performance status
LAPC Locally advanced pancreatic cancer
µm Micrometer
nab-paclitaxel Nanoparticle albumin-bound paclitaxel
OS Overall survival
PC Pancreatic cancer
PFS Progression-free survival
pts patients
RUNX3 Runt-related transcription factor 3
SMAD4 Mothers against decapentaplegic homolog 4
US United States